Matthew Sparks

All ELISAs that use biotin strepavidin at risk for this. Which are pretty much all ELISAs

SCM26 Fellows Debate Application Please click the link to complete this form.

🏆 Join the NIT Fellows’ Debate at SCM26! #NephFellows, here’s your chance to shine. Complimentary registration for selected participants.

Deadline: 12/1, 11:59pm ET

👉 Apply: bit.ly/4qp10y7

#MedEd #Nephrology @NephMadness

ATTN Fellows!!! Apply to be in the 3rd annual NephMadness NIT Fellows debate at NKF SCM in New Orleans

Application here

form.jotform.com/252084341700...

The 2025 #NephMadness logo dropped

#kidneywk

ajkdblog.org/2025/11/06/n...

#KidneyWk #HTNSecrets #Nephsecrets #NephSky
@hswapnil.medsky.social @kidneyboy.bsky.social @nephrosparks.bsky.social

Say no to #KidneyWk selfie smudges

Inspiration for Graham Gipson's #NephMadness 2026 logo: Roy Lichtenstein #KidneyWk

ajkdblog.org/2025/11/06/n...

The 2025 #NephMadness logo dropped

#kidneywk

ajkdblog.org/2025/11/06/n...

While having FOMO for not being at #KidneyWk , looking at the #NephMadness logo for 2026.

Can’t wait for it 🤩

Prabir Roy-Chaudhury opening up kidney week #kidneywk

Congrats Holly

🚨 Exciting news! Dr. Holly Kramer, MD, MPH, has been named the new Editor-in-Chief of Advances in Kidney Disease and Health (AKDH). 🌍🩺

Read the press release here: bit.ly/3JDtxiQ

#Nephrology #KidneyHealth #NephSky @akdhjournal.bsky.social @kidney.org

Just back from Orlando and Universal/Disney so I am well practiced and ready for this….

Can’t wait

My initial thoughts about aldosterone synthase inhibitors: why spend $$$$ to achieve what $4 of spironolactone can also achieve? Am I missing something?

#askrenal

Want to explore #nephrology? 🩺

The 2026 NephSim Nephrons #mentorship program pairs trainees with mentors & peers for 6 months of #education + networking.

Applications close Nov 13

Learn More: nephsim.com/nephsim-neph...

#MedEd #Nephrology @nephsim.bsky.social

NephSIM Nephrons - Applications for the 2026 NephSIM Nephrons & National Kidney Foundation Mentorship Program are now open for medical students & residents wanting to learn more about nephrology careers. Apply here by…

Calling all medical students & residents 📢 The 2026 NephSIM Nephrons program offers faculty mentorship, small group learning, & career panels in nephrology.

Deadline: Nov 13th
More Info:

Kidney Translation Podcasts 🎙️ from @asnkidney.bsky.social @asnpublications.bsky.social @nephrosparks.bsky.social
#Nephpearls #NephSky

👉🏼 journals.lww.com/asnjournals/...

New from #NephFaculty Dr Phekoo and PD Dr Sparks in @ASNPublications #Kidney360

Use of the Desmopressin Clamp in Hyponatremia: Smooth Sailing or Turbulent Waters?

journals.lww.com/kid...

NephJC 2025 Fall Pledge Drive — NephJC Help keep NephJC a vital, original, and unbiased source of medical education.

I donated to #NephJC

www.nephjc.com/news/2025/9/...

Take a listen to all of the @asnpublications.bsky.social ASN Kidney Translation Kidney Podcast series here

journals.lww.com/asnjournals/...

Had a great time at @nbluniv.bsky.social

Congrats to 10 years

NephMadness Canada trophy, ;)

Saturday is a dialysis day!, 🙏💛

ICYMI: the #NephJC @ajkd.bsky.social #NephMadness Canada kidney cup, cc: Dr. @nephrosparks.bsky.social resides in Atlantic Canada this year,🏆👊🤓😎#ThingsThatMakeYouSmile 🤓😃🙏💛

Could interleukin-6 have the potential to lead to treatments for calciphylaxis? The rare and life-threatening complication takes center stage in a new study described by Aarushi Varshney and Matthew Sparks. kidney.pub/KN1707-20 #ASNKidneyNews

@nephrosparks.bsky.social

A Day in the Life of a Duke Nephrology Fellow

⬇️
youtu.be/xnAjinYC1tA...

Baclofen Toxicity in Kidney Disease - PubMed Baclofen, a commonly prescribed muscle relaxant, is primarily excreted via the kidneys; toxicity is a potentially serious adverse outcome in patients with decreased kidney function. We describe a pati...

Also: baclofen in renal failure? 😱

pubmed.ncbi.nlm.nih.gov/28899601/

@nephrosparks.bsky.social

Exciting, clear, and concise summary by @nephrosparks.bsky.social and Dr. Arash Ataei of RGLS4326, a potential breakthrough in ADPKD research.
www.kidneynews.org/view/journal...

Could gene-targeted therapy be coming for autosomal dominant polycystic kidney disease? Farabursen, a new medication acquired by Novartis offers to potentially impact cyst formation and even regression. kidney.pub/KN1707-07 #ASNKidneyNews

@nephrosparks.bsky.social

Big Beautiful Bill is Downright Ugly for Kidney Patients Tune in for the latest research and perspectives on kidney health from NKF.

The so-called ‘Big Beautiful Bill’ that passed the Senate today is a giant leap backward for people living with kidney disease. NKF urges Congress to reject these harmful provisions. www.kidney.org/press-room/b...

The first installment of the ASN Transforming Vascular Access Together (TDAT) Videos is out

First installment is on how to identify vascular access types

Watch it here ✅

youtu.be/u6MXVL2lD7s